About Hopital Prive Jean Mermoz; Cancerologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hopital Prive Jean Mermoz; Cancerologie
During the past decade, Hopital Prive Jean Mermoz; Cancerologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)
2008-12-12
2017-07-27
Completed
2,825
A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)
2012-11-21
2015-03-25
Completed
551
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
2013-10-01
2016-10-01
Completed
271
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hopital Prive Jean Mermoz; Cancerologie
According to Clinical.Site data, the most researched conditions in "Hopital Prive Jean Mermoz; Cancerologie" are
"Breast Cancer" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Hopital Prive Jean Mermoz; Cancerologie" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Prive Jean Mermoz; Cancerologie
Most popular intervention types in "Hopital Prive Jean Mermoz; Cancerologie" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Fulvestrant" (1 trials), "Inavolisib" (1 trials), "Investigator's choice of anti-cancer treatment (except immunotherapy)" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Prive Jean Mermoz; Cancerologie
The vast majority of trials in "Hopital Prive Jean Mermoz; Cancerologie" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hopital Prive Jean Mermoz; Cancerologie
Currently, there are NaN active trials in "Hopital Prive Jean Mermoz; Cancerologie".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hopital Prive Jean Mermoz; Cancerologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Prive Jean Mermoz; Cancerologie, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".